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Background: After incomplete spinal cord injury (iSCI), patients suffer important
sensorimotor impairments, such as abnormal locomotion patterns and spasticity.
Complementary to current clinical diagnostic procedures, the analysis of muscle
synergies has emerged as a promising tool to study muscle coordination, which plays a
major role in the control of multi-limb functional movements.
Objective: Based on recent findings suggesting that walking and cycling share similar
synergistic control, the analysis of muscle synergies during cycling might be explored
as an early descriptor of gait-related impaired control. This idea was split into the
following two hypotheses: (a) iSCI patients present a synergistic control of muscles during
cycling; (b) muscle synergies outcomes extracted during cycling correlate with clinical
measurements of gait performance and/or spasticity.
Methods: Electromyographic (EMG) activity of 13 unilateral lower limb muscles was
recorded in a group of 10 healthy individuals and 10 iSCI subjects during cycling at four
different cadences. A non-negative matrix factorization (NNMF) algorithm was applied to
identify synergistic components (i.e., activation coefficients and muscle synergy vectors).
Reconstruction goodness scores (VAF and r2) were used to evaluate the ability of a given
number of synergies to reconstruct the EMG signals.
A set of metrics based on the similarity between pathologic and healthy synergies were
correlated with clinical scales of gait performance and spasticity.
Results: iSCI patients preserved a synergistic control of muscles during cycling. The
similarity with the healthy reference was consistent with the degree of the impairment,
i.e., less impaired patients showed higher similarities with the healthy reference.
There was a strong correlation between reconstruction goodness scores at 42 rpm
and motor performance scales (TUG, 10-m test and WISCI II). On the other hand,
the similarity between the healthy and affected synergies presented correlation with
some spasticity symptoms measured by Penn, Modified Ashworth and SCATS scales.
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Conclusion: Overall, the results of this study support the hypothesis that the
analysis of muscle synergies during cycling can provide detailed quantitative assessment
of functional motor impairments and symptoms of spasticity caused by abnormal
spatiotemporal muscle co-activation following iSCI.
Keywords: muscle synergies, spinal cord injury, cycling, spasticity, motor function
INTRODUCTION
The recovery of walking functions is one of the main goals
of rehabilitation of subjects with SCI (van Middendorp et al.,
2014). In this regard, one of the most promising directions
toward tailored interventions is the definition of reliable metrics
for the assessment of functional recovery on a quantitative
and fine-grained level. The main drawback of the current
clinical scales is the inability to grasp modest changes in
neurophysiological or functional improvements (Loftus, 2008;
Kirshblum et al., 2011; Gómez-Soriano et al., 2012; Bravo-
Esteban et al., 2014), due to the difficulty of measuring the
complex interplay of the impaired mechanisms emerging after
the lesion (Gómez-Soriano et al., 2010; Kennedy et al., 2012;
Bravo-Esteban et al., 2013; van Middendorp et al., 2014).
Among these, the development of the spasticity syndrome is
one of the crucial contributors for motor impairment (Bravo-
Esteban et al., 2013). Although the most common clinical
definition of spasticity is based on the velocity-dependent
properties of stretch reflex activity (Lance, 1980), this syndrome
involve other symptoms such as hypertonia, spasms, clonus,
hyperreflexia and muscle co-activation, all these correlated with
dysfunctional muscle activity (Burridge et al., 2005; Dietz and
Sinkjaer, 2007; Bennett, 2008; Arene and Hidler, 2009; Rosa
et al., 2014). As such, an improvement on the estimation of
muscle activity may represent an important outcome measure
of motor recovery after SCI (Awai and Curt, 2014). In
particular, the analysis of multi-joint muscle activation would
support clinical decisions based on residual useful motor
function, help to assess the effects of standard and novel
therapies, and guide the prescription of standard anti-spastic
medications (Bowden and Stokic, 2009; Reichenfelser et al.,
2012).
The analysis of muscle synergies has been referred to as a
reliable method to estimate muscle coordination and to gain
insights into motor control mechanisms in both healthy and
neurologically affected individuals (d’Avella and Bizzi, 2005; Bizzi
et al., 2008; Clark et al., 2010; Cheung et al., 2012; Berger et al.,
2013; Oliveira et al., 2014). The concept of muscle synergy has
been used with different meanings, depending on the context. In
neurorehabilitation, it refers to the stereotyped muscle activation
observed after lesions and due to a loss of independent control,
which results in abnormal and less flexible movement repertoires
(Howle, 2002). In contrast, in motor neuroscience it indicates
a strategy to simplify the motor control, in which a set of
muscles are organized in functional groups (Clark et al., 2010).
In the last 15 years, the neuroscientific perspective has gained
more and more relevance and will also be adopted along this
study. More specifically, this study will adopt the hypothesis
of “synchronous synergies” (Tresch and Jarc, 2009), in which
groups of muscles are activated in a fixed balance to produce
motor tasks. Within this hypothesis, every time a synergy is
activated, all the muscles within that same synergy will be
active.
Recent studies in healthy subjects demonstrated that the
combination of three to four muscle synergies can explain
most of the activation of lower limb muscles during walking
and cycling (Clark et al., 2010; Hug et al., 2010, 2011; Gizzi
et al., 2011; De Marchis et al., 2012; Barroso et al., 2013,
2014). In the case of poststroke patients, the number of muscle
synergies have been related to gait performance and proposed
as a potential alternative to gold-standard clinical scales (Clark
et al., 2010; Routson et al., 2013). In SCI patients, it has been
also observed that a disruption of muscle coordination plays
a major role in functional performance of overground walking
(Hayes et al., 2014). In particular, Ivanenko et al. (2003) showed
that muscle synergies of less impaired SCI subjects were more
similar to the healthy reference than those of the more affected
patients.
During the early stage of rehabilitation after the lesion, the
measurement of the gait-related motor abilities is particularly
difficult to be performed, due to the lack of the required
muscle strength to perform rhythmic movements while
maintaining appropriate upright posture. To solve this
problem, we hypothesized that cycling might be explored
as a novel tool for the measurement of gait-related motor
performance, based on the similar synergistic control of
walking and cycling in healthy controls (Barroso et al.,
2014).
This paper aims to test more directly whether pedaling
may be used to assess gait performance in patients with
iSCI. To this regard, we formulated two further hypotheses:
(i) synergistic control of muscles is preserved during cycling
after iSCI. (ii) muscle synergies extracted during cycling
correlate with clinical measurements of gait performance
and/or spasticity. The first hypothesis, apart from being a
prerequisite for testing the second hypothesis, has not been
investigated previously in the literature, being most of the
previous studies onmuscle synergies focused on locomotion. The
second hypothesis incorporates a clinically oriented question:
which is the most efficient experimental setup to extract
reliable results in clinical context? To answer this question,
we included in our experimental design different cycling
velocities and number of muscles, representing the variables
that mostly affect the duration of a typical clinical assessment
procedure.
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MATERIALS AND METHODS
Subjects
All recruited subjects gave their written consent to participate
in the study and for data publication, after being informed
about the procedures and possible discomfort associated with the
experiments, in accordance with the Declaration of Helsinki. The
local Toledo Paraplegics Hospital Clinical Ethical Committee
approved this study (07/05/2013 N◦47). Ten healthy subjects (6
men and 4 women), with an age of 33.9 ± 8.48 year (25.75 –
44.5, 25th percentile—75th percentile), with no diagnosed
neural injury, neither central nor peripheral, were recruited to
participate as controls. Ten iSCI patients (6 men and 4 women),
with an age of 43.08 ± 14.32 year (25.69 – 59.31), 7.23 ±
4.86 months (2.72 – 9.66) post-SCI, volunteered to participate
in this study. All of them received the standard rehabilitation
TABLE 1 | Individual iSCI patients’ description.
Patient Age Gender Time post-SCI Level of Most AIS
ID (Years) (months) Lesion affected
side
1 25 M 9 C5 Right C
2 46 M 6 T9 Left D
3 61 M 4 T10 Right D
4 25 M 5 T4 Left D
5 37 M 25 C3 Left D
6 19 F 2 C6 Right D
7 36 F 3 T3 Left D
8 58 F 2 C5 Right D
9 77 M 13 C7 Right D
10 44 F 5 C4 Left C
M, male; F, female; Level of Lesion: C, Cervical, T, Thoracic; AIS, American Spinal Injury
Association (ASIA) Impairment Scale.
program of the hospital. Inclusion criteria were: aged between
18 and 80 year; motor incomplete spinal lesion (AIS C-D)
of traumatic and non-traumatic etiology, with prognosis of
recovery of the walking function; evolution of at least 1.5 months.
Exclusion criteria were: supraspinal or peripheral neurological
involvement; history of epilepsy; musculoskeletal involvement
of lower limbs or spasticity higher than 3 (measured with the
Modified Ashworth Scale) for each joint, either for extension
or flexion. Detailed information of the patients is presented in
Table 1.
Experimental Protocol
Prior to the experiment, a trained physiotherapist performed a set
of clinical evaluations in order to inform about the clinical and
functional status of the patients. The hypertonia of the muscles
of the ankle and knee joints was evaluated using the modified
Ashworth scale (MAS, see Table 2; Bohannon and Smith, 1987).
The frequency of spasms was assessed using the Penn scale (Penn
et al., 1989). Patients were also assessed with the Spinal Cord
Assessment Tool for Spastic Reflexes (SCATS), which measures
three types of spastic reflexes in SCI patients: clonus, flexor
spasms and extensor spasms, each of them rated from 0 (no
reaction) to 3 (severe; Benz et al., 2005). Patients showing a Total
MAS higher than 1 or a Penn score greater or equal to 1 were
characterized as presenting the spasticity (see Table 2), as done
by Bravo-Esteban et al. (2014).
The gait performance of seven out of the ten iSCI patients was
evaluated using the Timed Up and Go (TUG) test (Wall et al.,
2000) and the 10-m test (Forrest et al., 2014). The other three
patients were unavailable to perform these tests. The Walking
Index for Spinal Cord Injury (WISCI II) was used to assess the
amount of physical assistance needed by the patients to walk 10
m. This is a 21-point scale that ranges from 0 (patient unable
to stand and/or participate in assisted walking) to 20 (patient
ambulates 10m with no devices, no braces and no physical
assistance; Dittuno and Ditunno, 2001).
TABLE 2 | Amount of physical assistance needed, gait performance, and spasticity syndrome scores of iSCI patients.
Patient ID WISCI II TUG (s) 10-m (s) MAS MAS Knee MAS Ankle Total MAS Penn scale SCATS
KF KE DF PF C F E
1† 16 22.0 23.0 1 1 1 1 2 2 4 2 1 0 1
2 20 23.0 12.0 0 0 0 0 0 0 0 0 0 0 0
3† 16 44.7 50.8 0 1+ 1+ 0 2 2 4 1 1 0 0
4† 15 29.3 27.7 2 1 3 0 4 4 8 1 1 0 1
5† 20 N.A. N.A. 0 1+ 3 0 2 4 6 1 0 1 1
6† 0 N.A. N.A. 1+ 2 3 0 5 4 9 2 3 1 0
7† 16 31.0 30.0 1+ 0 1+ 0 2 2 4 0 2 0 0
8 13 27.0 23.0 0 0 0 0 0 0 0 0 0 0 0
9 19 25.1 10.2 0 0 0 0 0 0 0 0 0 0 0
10† 8 N.A. N.A. 0 0 3 0 0 4 4 3 3 0 3
WISCI II, Walking Index for Spinal Cord Injury; TUG, Timed Up and Go; MAS, Modified Ashworth Scale; KF, knee flexion; KE, knee extension; DF, dorsiflexion; PF, plantarflexion. MAS
Knee, sum of KF and KE. In order to sum, 1+ counts as 2, 2 counts as 3, 3 counts as 4 and 4 counts as 5; MAS Ankle, sum of DF and PF; Total MAS, sum of MAS Knee and MAS
Ankle; Penn, Penn scale; SCATS, Spinal Cord Assessment Tool for Spastic Reflexes; Types of spastic reflexes: C, clonus; F, flexion; E, extension; N.A., measure not available; †, patients
characterized as presenting the spasticity syndrome.
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On the day of the experiment, patients received their standard
rehabilitation therapy in the morning, and performed the cycling
trials in the afternoon. For both iSCI patients and healthy
subjects, four cycling trials (at 30, 42, 50, and 60 rpm, revolutions
per minute) of 30 s duration each, with 60 s resting between trials,
were performed on an electronically braked cycle ergometer
(MOTOmed viva2, Reck, Betzenweiler, Germany). For each
participant, the order of the trials was randomized to avoid biased
results. All participants were asked to perform the experiment
while sat on a regular chair. Patients who felt more comfortable
doing the experiments on their own wheelchair were allowed to
remain sat on it. When this occurred, a pillow was placed on the
backside to maintain the pedaling position similar to the regular
chair position.
An auditory metronome was used to synchronize participants’
cycling frequency with the desired cadence. The cycling
resistance (gear) of the ergometer was individually chosen by
each iSCI patient, in order to cycle comfortably with the same
gear across the four cadences. A constant gear was set for all
control subjects.
Data Collection
A surface electromyography (sEMG) acquisition system (EMG-
USB, OT Bioelettronica, Torino, Italy) was used to record the
activity of 13 muscles of the most affected leg of patients,
and the dominant leg of healthy subjects. The recorded
muscles were: Gluteus Medius (GMe), Adductor Longus (AL),
Sartorius (Sar), Tibialis Anterior (TA), Rectus Femoris (RF),
Tensor Fascia Latae (TFL), Vastus Lateralis (VL), Vastus
Medialis (VM), Biceps Femoris (BF), Semitendinosus (Sem),
Soleus (Sol), Gastrocnemius Lateralis (GaL), and Gastrocnemius
Medialis (GaM). We determined the most affected side of
each patient based on the muscle score (Seddon, 1976)
of quadriceps, hamstrings, TA and gastrocnemius for both
limbs. The EMG amplifier had a recording bandwidth of 10–
750Hz, overall gain of 1000V/V, and acquisition frequency
of 2048Hz. SENIAM recommendations for sEMG recording
procedures (Hermens et al., 1999) were followed before placing
the electrodes: shaving the places where the electrodes were
placed; cleaning the skin with alcohol to minimize impedance;
allowing the alcohol to vaporize in order to dry the skin before
placing the electrodes. After that, bipolar electrodes (Ag-AgCl,
AmbuNeuroline 720, Ambu, Ballerup, Denmark) were fastened
with a 2-cm interelectrode distance on each recorded muscle.
Finally, the electrodes and cables were wrapped with bandages
to ensure that the wires did not impede cycling movements
and also to avoid movement-induced artifacts. Preliminary tests
were performed to check for cross-talk and contact artifacts,
giving special attention to the hamstrings of those patients that
cycled on their own wheelchair. When needed, electrodes were
repositioned.
Crank angle was measured with a potentiometer (Vishay,
Malvern, PA), and digitalized with a sampling frequency of
100Hz. The bottom dead center (BDC) position of the pedal
of the analyzed leg was used to segment data into pedaling
cycles. EMG and angular data were synchronized by means of
a common synchronization signal.
Data were analyzed oﬄine with MATLAB R2011a (The
MathWorks, Natick, MA) and IBM SPSS Statistics 20 software
(IBM).
Muscle Synergies Extraction
For each trial and participant, the ten consecutive central cycles
were selected for analysis. The selected raw EMG signals were
high-pass filtered at 20Hz, demeaned, rectified, and smoothed
with a low-pass filter at 5Hz, resulting in the EMG envelopes
(Clark et al., 2010; Hug et al., 2010; Barroso et al., 2014). EMG
envelopes from each muscle were then normalized by the average
of the maximum of each of the ten cycles, and resampled at each
1% of the cycling cycle. For each participant and trial, normalized
EMG envelopes were combined into an m × t matrix (EMG0),
where m is the number of muscles (thirteen in this case) and t is
the time base [t = no. of cycles (10)× 100)].
Differences between mean EMG envelopes of iSCI patients
and the mean EMG envelopes of the healthy group were
assessed with the rmax coefficient (Hug et al., 2011), which is
the maximum of the cross-correlation between two signals. The
cross-correlation is calculated by the MATLAB xcorr function
for centered data (option = “coeff”) and the output values as
the maximum of the cross-correlation function, which gives an
indication of the similarity of shape of the EMG envelopes.
Muscle synergies were extracted using the Non-Negative
Matrix Factorization (NNMF) algorithm (Lee and Seung, 1999).
Mathematically, the output of the algorithm is the following:
EMG0 =WH+ e = EMGr+ e (1)
where W is a m × n matrix (n is the number of synergies)
that specifies the relative weighting of each muscle within each
synergy (hereafter, each column ofWwill be referred to asmuscle
synergy vector); H is a n × t matrix that specifies the time-
varying activation coefficients, which represent the recruitment
of each synergy vector over time; EMGr, is an m × t matrix
resulting from the multiplication of W and H, representing the
reconstructed EMG envelopes; e is the residual error. For each
EMG0, we run the NNMF algorithm four times, considering as
input 2 to 5 synergies (n = 2, 3, 4, 5). In order to avoid local
minima, for each run, the NNMF was repeated 40 times and the
repetition with the lowest reconstruction error was selected.
The similarity between EMG0 and EMGr was calculated based
on two reconstruction goodness scores: the variability accounted
for (VAFtotal; Clark et al., 2010; Barroso et al., 2014) and the
coefficient of determination (r2; Torres-Oviedo et al., 2006).
VAFtotal is described in Equation (2).
VAFtotal = 1−
∑m
i=1
∑t
j=1
(
EMG0
(
i, j
)
− EMGr
(
i, j
))2
∑m
i=1
∑t
j=1
(
EMG0
(
i, j
))2 (2)
The coefficient of determination was calculated by the MATLAB
function “rsquare.” VAF was also computed for each muscle
individually (VAFmuscle). Both VAFtotal and r
2 have been adopted
in most studies on muscle synergies (Torres-Oviedo et al., 2006;
Clark et al., 2010; Barroso et al., 2014). VAFtotal has been
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FIGURE 1 | Group average electromyographic (EMG) envelopes of the 13 recorded muscles for each of the four speeds during cycling (30, 42, 50, and
60 rpm). For each group (healthy subjects, thin lines; iSCI patients, thick lines), a total of 100 cycling cycles (10 cycles by subject) were averaged and expressed as a
function of the pedaling cycle. Pedaling cycle begins when the pedal corresponding to the dominant leg (in healthy subjects) or the most affected leg (in iSCI subjects)
is at the lowest position and ends when the pedal reaches the lowest position again. EMGs from each subject and muscle were previously normalized by the average
of its maximum values throughout the 10 cycles. a.u., arbitrary unit. *, muscles belonging to the eight muscles set used in parallel analysis. Number indicate lag times
that maximized the cross-correlation function. A negative value indicates that the mean EMG envelopes of iSCI patients shifted earlier in the cycle relative to the mean
EMG envelopes of healthy group.
suggested to be more stringent than r2, since it is sensitive to both
shape and amplitude of the signals, whereas r2 only addresses
similarity in shape.
Each muscle synergy vector (column of matrix W) was
normalized by themaximum value of themuscle in the synergy to
which they belong, and the corresponding activation coefficients
(lines of matrix H) were scaled by the same quantity (De Marchis
et al., 2012; Barroso et al., 2014).
For each cadence, we obtained a reference set of matrices
(hereafter called W0 and H0) by pooling the EMG envelopes
from all the healthy subjects, and applying the NNMF algorithm,
constrained to a fixed number of synergies. This fixed number
was defined as the minimum number of synergies needed to
obtain VAFtotal values ≥ 85% in at least half of the healthy
participants. Synergy vectors of each patient were ordered
according to their similarity with columns of W0, at the
corresponding matched speeds. This was done by means of the
normalized scalar product (Barroso et al., 2014). After being
ordered, muscle synergy vectors and activation coefficients of
each patient were compared with the reference healthy set (W0
and H0) using the normalized scalar product.
In order to study the sensitivity of the method to the
number of muscles, we repeated the overall process on two
muscle datasets, the first including all (13) muscles recorded
in the experiment, and the second including the eight muscles
considered in our previous study (Barroso et al., 2014). These
eight muscles are marked with an asterisk in Figure 1.
Statistical Analysis
Independent Student’s t-tests were computed to test the similarity
between the cadences achieved by both groups, at each matched
speed. Independent Student’s t-tests were also performed to test
the similarity of the VAFtotal and r
2 scores between the two
groups and between spastic and non-spastic patients, when using
2 to 5 synergies.
Spearman’s Rank-Order correlations (rs) were performed to
evaluate the monotonic relationship between reconstruction
goodness scores (obtained for each different number of muscle
dataset and speed) and gait performance scales (WISCI II,
TUG and 10-m tests). Spearman’s Rank-Order correlations were
also used to evaluate the relationship between the normalized
scalar products between H and H0 and between W and W0
(hereafter denoted with “H · H0” and “W · W0”) and spasticity
scales scores (Total MAS, Penn and spastic reflexes from
SCATS).
Statistical significance was set by a p-value of 0.05.
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RESULTS
Muscle Synergy Analysis
Cadence
SCI group cycled with a cadence of (mean ± SD) 30.26 ±
0.87, 41.89 ± 1.04, 49.71 ± 1.91, and 57.73 ± 3.57 rpm for the
desired speeds of 30, 42, 50, and 60 rpm, respectively. The healthy
group cycled with a cadence of 30.21 ± 0.34, 42.21 ± 1.15,
49.25 ± 0.76, and 59.79 ± 0.90 rpm, respectively. The tests of
equality of means from Independent Student’s t-tests revealed no
significant differences between the two groups, in any of the four
speeds considered. In particular, p-values of 0.868, 0.516, 0.492,
and 0.093 were obtained for speeds of 30, 42, 50, and 60 rpm,
respectively.
Individual EMG Profiles
The average EMG envelopes of each group, for each of the
13 recorded muscles, are represented in Figure 1. Average
activations of GMed, AL, Sar, TA and, to a lower extent, RF,
occurred during the initial upstroke phase. Average activations
of TFL, VL, and VM were observed during the final upstroke
phase and initial downstroke. Average activation of BF, Sem, Sol,
GaL, and GaM occurred mostly during the downstroke phase of
cycling.
For each muscle, the shape and activation timing of average
EMGs were very similar across speeds and also between the
two groups, except for TA, VM, Sol, and GaL. In the case of
these four muscles, the timing of maximum activation occurred
earlier in the pedaling cycle in the iSCI patients, as indicated by
the lag times in Figure 1. On the other hand, maximum values
of the cross-correlation function were lower for Sol and GaL,
when compared with the other muscles. For these two muscles,
maximum correlations were lower than 0.85, while maximum
correlations were higher than 0.95 for the other muscles at most
of the speed conditions.
Reconstruction Goodness Scores
According to our criterion defined previously (VAFtotal values ≥
85% for at least half of the healthy participants), three synergies
were sufficient to describe most of the variance of the two
different sets of muscles in the two groups of participants
analyzed. For this reason, our analysis along the paper is based
on this number of synergies.
For the set of 8 muscles, both groups reached their minimum
values of VAFtotal at the speed of 60 rpm. The VAFtotal values in
such condition were 86.7 ± 2.0% (Figure 2AI) for the healthy
group and 86.6 ± 3.1% (Figure 2AII) for the iSCI group. The
maximumVAFtotal was obtained at the speed of 30 rpm, reaching
values of 88.5 ± 4.2% and 88.2 ± 3.9% for the healthy and iSCI
groups, respectively.
When analyzing VAFmuscle values with three synergies for the
set of 8 muscles, all the muscles presented values higher that
75%. For instance, in the case of the healthy group, a minimum
VAFmuscle value of 83.0 ± 13.0% was obtained for Sem at the
speed of 30 rpm; a maximum VAFmuscle value of 91.9 ± 4.7%
was obtained for VL at the speed of 50 rpm. In the case of the
iSCI group, a minimum VAFmuscle value of 75.6 ± 8.4% was
obtained for GMe at the speed of 60 rpm; a maximum VAFmuscle
value of 91.0 ± 2.4% was obtained for GaM at the speed of
30 rpm.
VAFtotal values decreased when considering the complete
set of 13 muscles. The minimum values of 84.0 ± 2.2%
(Figure 2AIII) and 83.1 ± 4.0% (Figure 2AIV) were obtained
for the healthy and iSCI group, respectively. In this case, the
healthy group reached minimum VAFtotal values at the speed of
60 rpm, whereas iSCI group reached its minimum at the speed of
50 rpm. The maximum values of 86.0 ± 4.6% and 85.2 ± 4.2%
were obtained for the healthy and iSCI group, respectively, both
at 30 rpm.
When analyzing VAFmuscle values with three synergies for the
set of 13 muscles, all the muscles presented values higher that
75%, except for one muscle and condition in the iSCI group.
Specifically for the case of iSCI group, a minimum VAFmuscle
value of 73.8 ± 10.8% was obtained for GMe at the speed of
60 rpm; a maximumVAFmuscle value of 87.4± 3.3% was obtained
for BF at the speed of 60 rpm. In the case of the healthy group, a
minimum VAFmuscle value of 77.2 ± 11.1% was obtained for AL
at the speed of 42 rpm; a maximum VAFmuscle value of 91.9 ±
4.6% was obtained for VL at the speed of 30 rpm.
The tests of equality of means from Independent Student’s
t-tests revealed no significant differences for the VAFtotal scores
between the two groups and also between spastic and non-spastic
patients, for the four studied speeds, when using 2 to 5 synergies
as input to the NNMF algorithm.
In the case of the r2 coefficient, a minimum of 0.70 ± 0.05
(Figure 2BI) and 0.69± 0.06 (Figure 2BII) were obtained for the
healthy and iSCI group, respectively, for the set of 8muscles. Both
values were obtained for the speed of 60 rpm. On the other hand,
a maximum of 0.73± 0.09 and 0.72± 0.06 were obtained for the
healthy and iSCI group, respectively. Both values were obtained
for the speed of 30 rpm.
As it happened for VAFtotal, also r
2 values decreased in the case
of 13-muscle dataset. A minimum of 0.63 ± 0.08 (Figure 2BIII)
and 0.61 ± 0.06 (Figure 2BIV) were obtained for the healthy (at
42 rpm) and iSCI group (at 60 rpm), respectively. A maximum of
0.67 ± 0.91 and 0.65 ± 0.07 were obtained for the healthy and
iSCI group, respectively, both at 30 rpm.
The tests of equality of means from Independent Student’s
t-tests revealed no significant differences for the r2 scores
between the two groups and also between spastic and non-spastic
patients, for all speeds and input number of synergies.
Synergy Vectors and Activation Coefficients
The reference sets of three muscle synergy vectors (W0) and
the corresponding activation coefficients (H0) of the healthy
group at four different speeds are represented in Figures 3AI,II,
respectively. Synergy 1, activated predominantly during the
upstroke phase of cycling (see Figure 3AII), was represented by
the activity of GMed, AL, Sar, TA, and RF. Synergy 2, activated
during the final upstroke phase and initial downstroke phase of
cycling, was represented by the activity of TFL, VL, VM and,
to a lower extent, TA and RF. Synergy 3, activated during the
downstroke phase of cycling, was composed by the activity of BF,
Sem, Sol, GaL, and GaM.
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FIGURE 2 | Variability accounted for (VAFtotal) (A) and coefficient of determination (r
2) (B) according to the number of synergies, for each of the four
speeds (30, 42, 50, and 60 rpm). Values are given in means ± SD. These reconstruction goodness indexes were calculated after running the NNMF algorithm to
reconstruct a set of 8 EMG envelopes for the healthy group (I) and the iSCI group (II), as well as a set of 13 EMG envelopes (III and IV for the healthy group and iSCI
group, respectively). A VAFtotal value of 100% and a r
2 value of 1 mean perfect reconstruction of the EMG set. *Number of synergies sufficient to describe VAFtotal
values ≥ 85% for at least half of the healthy participants.
Results from a representative iSCI patient (ID 04) with
spasticity are represented in Figures 3BI,II. High variability
of muscle synergy vectors and activation coefficients can be
observed across speeds. This is reflected in the values of
normalized scalar product between muscle synergy vectors W
extracted with the set of 13 muscles, and the reference matrices
W0 (W ·W0). This ranged from 0.41 to 0.69 in synergy 1, from
0.57 to 0.78 in synergy 2, and from 0.74 to 0.90 in synergy 3
(see Table 3). In the case of activation coefficients, H ·H0 ranged
from 0.63 to 0.91 for activation coefficient 1, from 0.59 to 0.90
for activation coefficient 2, and from 0.50 to 0.87 for activation
coefficient 3. When only 8 muscles were considered, W · W0
ranged from 0.41 to 0.66 for synergy vector 1, from 0.70 to 0.73
for synergy vector 2, and from 0.74 to 0.96 for synergy vector
3 (see Table 4). Normalized scalar product ranged from 0.60 to
0.81 for activation coefficient 1, from 0.58 to 0.88 for activation
coefficient 2, and from 0.61 to 0.90 for activation coefficient 3.
Results from a representative iSCI patient (ID 09) without
spasticity are represented in Figures 3CI,II. In this case, muscle
synergy vectors and activation coefficients were very similar
across the speeds, as it happened in the healthy group. W · W0
ranged from 0.57 to 0.81 for synergy 1, from 0.88 to 0.95 for
synergy 2, and from 0.83 to 0.96 for synergy 3 (seeTable 3). In the
case of activation coefficients, H ·H0 ranged from 0.65 to 0.87 for
activation coefficient 1, from 0.92 to 0.95 for activation coefficient
2, and from 0.78 to 0.92 for activation coefficient 3. For the set of
8 muscles, W ·W0 ranged from 0.70 to 0.77 for synergy vector 1,
from 0.76 to 0.89 for synergy vector 2, and from 0.88 to 0.97 for
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FIGURE 3 | Reconstruction of EMG envelopes in four speeds (30, 42, 50, and 60 rpm) using concatenated data from the 10 healthy subjects (A), and
individual data from a patient with spasticity—ID 04 (B) and a patient without spasticity—ID 09 (C), applying the NNMF algorithm with three synergies.
I: muscle synergy vectors. Each muscle synergy vector has a time-invariant profile, representing the relative contribution of each synergy for each muscular pattern.
Muscle synergy vectors were normalized by their maximum value. II: averaged activation coefficients, indicating time-variant profiles responsible to activate each
synergy.
synergy vector 3 (see Table 4). As for the activation coefficients,
H · H0 ranged from 0.78 to 0.95 for synergy 1; 0.91 to 0.97 for
synergy 2; 0.72 to 0.93 for synergy 3.
When comparing these similarity values between spastic and
non-spastic patients, most of the metrics presented a lower mean
in spastic patients, despite those differences were not statistically
significant. Just in the case of H2 ·H02 at 30 rpm for the dataset of
13 muscles, differences were significant (p = 0.036), with spastic
patients (0.9± 0.04) presenting lower similarity than non-spastic
(0.94± 0.02).
Normalized scalar products between synergy vector 3 (W3)
from each iSCI patients and the corresponding synergy vector
from the healthy group (W03) were, on average, higher than those
obtained for W1 and W2, for all speeds (see Tables 3, 4), in both
sets of 13 and 8 muscles. In general, normalized scalar products
were higher at lower speeds. Also, normalized scalar products
using the set of 13 muscles were higher than those observed with
the set of 8 muscles at 30 rpm, and lower for the other speeds.
Normalized scalar products of activation coefficient 3 from
each iSCI patient (H3) and activation coefficient 3 from the
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TABLE 3 | Normalized scalar product between matching muscle synergy vectors from matrices W of each patient and the matrix W0 obtained from all
healthy subjects pooled together, considering the set of 13 muscles.
Patient ID W · W0 at 30 rpm W · W0 at 42 rpm W · W0 at 50 rpm W · W0 at 60 rpm
1 2 3 1 2 3 1 2 3 1 2 3
1 0.48 0.71 0.79 0.64 0.67 0.78 0.60 0.78 0.68 0.74 0.68 0.78
2 0.91 0.89 0.99 0.92 0.81 0.91 0.87 0.73 0.90 0.87 0.79 0.88
3 0.55 0.83 0.96 0.58 0.84 0.95 0.40 0.78 0.91 0.46 0.73 0.95
4 0.62 0.78 0.90 0.61 0.68 0.74 0.69 0.57 0.85 0.41 0.71 0.79
5 0.79 0.88 0.94 0.78 0.80 0.90 0.75 0.77 0.93 0.93 0.90 0.88
6 0.73 0.54 0.73 0.45 0.58 0.67 0.73 0.65 0.61 0.67 0.76 0.76
7 0.96 0.96 0.96 0.93 0.97 0.94 0.88 0.77 0.68 0.86 0.89 0.85
8 0.70 0.69 0.86 0.50 0.75 0.85 0.70 0.31 0.66 0.74 0.39 0.78
9 0.76 0.95 0.83 0.68 0.92 0.83 0.81 0.89 0.96 0.57 0.88 0.85
10 0.54 0.80 0.93 0.71 0.78 0.97 0.44 0.83 0.85 0.40 0.88 0.82
Mean 0.71 0.80 0.89 0.68 0.78 0.85 0.69 0.71 0.80 0.67 0.76 0.83
(SD) (0.13) (0.10) (0.07) (0.12) (0.09) (0.08) (0.12) (0.12) (0.12) (0.16) (0.11) (0.05)
The scalar product was abbreviated with the notation “W · W0.” Values ≥ 0.9 appear in bold.
TABLE 4 | Normalized scalar product between matching muscle synergy vectors from matrices W of each patient and the matrix W0 obtained from all
healthy subjects pooled together, considering the set of 8 muscles.
Patient ID W · W0 at 30 rpm W · W0 at 42 rpm W · W0 at 50 rpm W · W0 at 60 rpm
1 2 3 1 2 3 1 2 3 1 2 3
1 0.37 0.74 0.84 0.73 0.67 0.71 0.69 0.87 0.81 0.59 0.78 0.75
2 0.83 0.73 0.98 0.87 0.72 0.86 0.82 0.51 0.87 0.95 0.70 0.84
3 0.80 0.76 0.97 0.79 0.81 0.96 0.81 0.89 0.95 0.68 0.83 0.97
4 0.66 0.73 0.96 0.60 0.70 0.86 0.46 0.72 0.82 0.41 0.71 0.74
5 0.76 0.73 0.98 0.73 0.65 0.78 0.39 0.74 0.82 0.95 0.83 0.70
6 0.36 0.58 0.71 0.52 0.89 0.85 0.79 0.86 0.69 0.56 0.83 0.88
7 0.68 0.87 0.81 0.96 0.93 0.99 0.70 0.56 0.87 0.94 0.75 0.93
8 0.54 0.70 0.78 0.84 0.91 0.95 0.93 0.57 0.81 0.94 0.79 0.85
9 0.75 0.89 0.88 0.70 0.81 0.91 0.77 0.85 0.97 0.75 0.76 0.93
10 0.22 0.80 0.83 0.12 0.88 0.85 0.15 0.88 0.78 0.23 0.78 0.84
Mean 0.60 0.75 0.87 0.69 0.80 0.87 0.65 0.74 0.84 0.70 0.78 0.84
(SD) (0.18) (0.06) (0.08) (0.16) (0.09) (0.06) (0.19) (0.12) (0.06) (0.20) (0.04) (0.07)
The scalar product was abbreviated with the notation “W · W0.” Values ≥ 0.9 appear in bold.
healthy group (H03) were, on average, higher than those obtained
for H1 and H2, for all speeds and sets of muscles.
Correlation with Clinical Metrics
Correlation with Gait Performance Scores
Spearman’s rank-order correlations were run to determine the
relationship between reconstruction goodness scores (VAFtotal
and r2) and clinical measurements of gait performance of iSCI
patients. There was a strong, positive correlation between EMG
reconstruction goodness scores when using the set of 13 muscles
andWISCI II scores, which was statistically significant (rs > 0.75,
p < 0.05; see Table 5). Significant correlations were also found
between WISCI II and VAFtotal and r
2 for the speed 42 rpm,
when using the set of 8 muscles. Two examples of the correlation
betweenWISCI II and reconstruction goodness indexes (VAFtotal
and r2) at 42 rpm are represented in Figures 4C,F, respectively.
The r2 index correlated negatively with TUG and 10-m tests,
in both cases of 13 and 8 muscles, for 42 rpm, as represented
in Table 5 and Figures 4D,E. VAFtotal with 8 muscles also
presented significant correlation with TUG scores, at 42 rpm.
The correlation of 10-m test with VAFtotal presented a p-value of
0.058, for the set of 8 muscles. Correlations between VAFtotal and
TUG and 10-m tests, at 42 rpm, are presented in Figures 4A,B,
respectively.
Correlation with Spasticity Measures
Significant correlations were found, especially for the set of 8
muscles, with the Penn scale. For instance, W1 ·W01 correlated
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TABLE 5 | Correlation of gait scales (from iSCI patients) with VAFtotal and r
2 results of the EMG reconstruction with 8 and 13 muscles, for all speeds.
8 Muscles 13 Muscles
30 rpm 42 rpm 50 rpm 60 rpm 30 rpm 42 rpm 50 rpm 60 rpm
V
A
F
to
ta
l
TUG r = 0.029 r = −0.833* r = 0.124 r = 0.076 r = −0.115 r = −0.629 r = 0.174 r = −0.121
p = 0.950 p = 0.020 p = 0.791 p = 0.871 p = 0.806 p = 0.130 p = 0.709 p = 0.796
10-m r = −0.001 r = −0.739 r = 0.167 r = 0.079 r = −0.219 r = −0.643 r = 0.078 r = −0.243
p = 0.998 p = 0.058 p = 0.720 p = 0.866 p = 0.637 p = 0.119 p = 0.868 p = 0.599
WISCI II r = 0.472 r = 0.650* r = 0.350 r = 0.402 r = 0.845** r = 0.850** r = 0.809** r = 0.749*
p = 0.168 p = 0.042 p = 0.322 p = 0.250 p = 0.002 p = 0.002 p = 0.005 p = 0.013
r2
TUG r = −0.002 r = −0.934** r = −0.094 r = −0.082 r = −0.235 r = −0.777* r = −0.115 r = −0.420
p = 0.997 p = 0.002 p = 0.841 p = 0.862 p = 0.612 p = 0.040 p = 0.806 p = 0.348
10-m r = −0.057 r = −0.843* r = −0.039 r = −0.055 r = −0.383 r = −0.817* r = −0.204 r = −0.541
p = 0.904 p = 0.017 p = 0.934 p = 0.907 p = 0.397 p = 0.025 p = 0.661 p = 0.210
WISCI II r = 0.542 r = 0.677* r = 0.412 r = 0.228 r = 0.899** r = 0.825** r = 0.825** r = 0.794**
p = 0.106 p = 0.032 p = 0.236 p = 0.527 p = 0.000 p = 0.003 p = 0.003 p = 0.006
Significant correlation values (p < 0.05) appear in bold. *Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
FIGURE 4 | Correlation between walking tests scores in iSCI patients and reconstruction goodness indexes at 42 rpm, for the sets of 8 and 13
muscles. VAFtotal scores correlated negatively with TUG (A) and 10-m (B) tests; VAFtotal scores correlated positively with WISCI II (C). r
2 scores correlated negatively
with TUG (D) and 10-m (E) tests; r2 scores correlated positively with WISCI II (F).
negatively (p < 0.05, rs<0) with Penn scale for all speeds,
except for 50 rpm (p = 0.076; see Table 6). W3 ·W03 correlated
negatively (p < 0.05, rs< 0) with Penn scale for 42 and
50 rpm speeds. The trend found when correlating Penn with
W3 · W03 at 42 rpm is represented in Figure 5A. In this case,
patients with higher Penn scores presented lower similarity on
W3 ·W03.
Some correlations with clonus and extensor spasms assessed
with SCATS were also significant (p < 0.05) or presented
p-values between 0.05 and 0.1 for some of the similarity
scores and speeds, for the set of 8 muscles. The trend found
when correlating clonus from SCATS with W1 · W01 at
42 rpm is represented in Figure 5B. In this case, patients
with higher SCATS scores presented lower similarity on
W1 ·W01.
Total MAS correlated negatively (p < 0.05, rs< −0.75)
with H2 · H02 at 30 rpm, for the set of 8 muscles. The
trend found when correlating Total MAS with H2 · H02
at 42 rpm and 30 rpm for the sets of 8 and 13 muscles,
respectively, is represented in Figures 5C,D. For both cases,
patients with higher Total MAS scores presented lower similarity
on H2 ·H02.
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FIGURE 5 | Correlation between spasticity scales in iSCI patients and W · W0, and H · H0 scores. For the set of 8 muscles at 42 rpm, W3 · W03 correlated
negatively with PENN (A) and W1 ·W01 correlated negatively with clonus spasms assessed with SCATS (B). H2 · H02 correlated negatively with Ashworth for the sets
of 8 muscles at 42 rpm (C) and 13 muscles at 30 rpm (D). *Correlation is significant at the 0.05 level (2-tailed). **Correlation is significant at the 0.01 level (2-tailed).
DISCUSSION
The results of this work support the hypothesis that iSCI patients
preserve a synergistic control of cycling, being this evidence not
reported previously in the literature. The second relevant finding
of this work is that gait motor performance and spasticity of
iSCI patients correlate with muscle synergies outcomes extracted
during cycling movements. In particular, synergy reconstruction
goodness scores (VAF, r2) correlate with walking performance
scales scores, whereas the degree of similarity between iSCI
and healthy synergies appears to be correlated with spasticity
scales scores, especially the spasms frequency measured by Penn
scale. The next section discusses these findings in more detail,
providing additional reasoning for their correct interpretation.
Muscle Synergy Analysis
Electromyographic Patterns in iSCI Patients during
Cycling
With the exception of TA, VM, GaL, and Sol, the average EMG
envelopes of all muscles presented very similar activation timing
and shape between the two groups, along all matched speeds. In
the case of the three aforementioned distal muscles (TA, GaL,
and Sol), which are usually affected by spasticity (Bravo-Esteban
et al., 2013) and co-activation (Gómez-Soriano et al., 2010), we
hypothesize that the differences in the average activation timing
and shape could be explained by the hypertonia and clonus
presented by some of the patients recruited.
Several studies have previously showed that the EMG activity
of lower limb muscles is similar between sides, during tasks like
walking and cycling in healthy subjects (Clark et al., 2010; Gizzi
et al., 2011; Hug et al., 2011). For this reason, we analyzed only the
dominant leg of healthy participants. In the case of iSCI patients,
we considered the most affected side, in order to extract more
relevant information on the underlying impairments.
In addition to the eight muscles studied previously by us in
healthy subjects (Barroso et al., 2014), five additional muscles
(mono and bi-articular) have been recorded to increase the
sample number and to test the influence of the number ofmuscles
required to correlate synergy metrics with clinical scales.
As part of the standard rehabilitation program of the hospital,
patients were already trained in the use of MOTOmed viva2.
Therefore, we did not expect any temporal effect on muscle
activation.
Reconstruction Goodness Scores
To assess the reconstruction goodness of EMG patterns with a
given number of synergies, we used two different coefficients:
VAFtotal and coefficient of determination (r
2). In our previous
study (Barroso et al., 2014), we obtained VAFtotal values of
approximately 90% using three synergies, to reconstruct a set of
eight lower limb muscles in eight healthy subjects, for cycling
speeds ranging from 43 ± 2.7 to 70 ± 4.0 rpm. In this study,
similar VAFtotal values (86.7± 2.0 to 88.5± 4.2%) were obtained
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for the same set of muscles in ten healthy subjects. As expected,
both VAFtotal and r
2 values decreased when using three synergies
to reconstruct the set of 13muscles, when compared with the case
of 8 muscles. As referred by Steele et al. (2013), Clark et al. (2010),
and Monaco et al. (2010), the higher the number of muscles,
the lower is the reconstruction goodness score. No significant
differences were found in the VAFtotal and r
2 scores neither
between the iSCI group and the healthy group nor between
spastic and non-spastic patients, for the 4 speeds, when using 2 to
5 synergies. This result may be explained by the low complexity of
cycling (few degrees of freedom), which seems to be executed by
the same number of synergies by both healthy and iSCI subjects.
Differently from previous studies, in which VAF is used to
define the optimal number of synergy for each subject, we
introduced a global criterion (VAFtotal values ≥ 85% in at least
50% of the subjects) in order to fix a “globally optimum” number
of synergies for all subjects. This criterion allowed us to (i) use
VAFtotal values as a continuous quantitative metric of motor
performance, and (ii) perform a direct comparison between
patients’ synergies and a standardized reference dataset (W0
and H0).
Similarity of Synergy Vectors and Activation
Coefficients
Little is known about the effect of iSCI on muscle synergies
(Ivanenko et al., 2009). The few studies that investigated this
synergistic control focused on gait (Ivanenko et al., 2003, 2009;
Hayes et al., 2014). These studies suggested that the training
post-SCI and the underlying plasticity lead to a reorganization
of interneuronal networks, this way modifying and creating new
muscle synergies. Notwithstanding, the synergistic control of
iSCI patients during cycling has not been described yet, to our
best knowledge.
Interestingly, the activation coefficients when using the set
of 13 muscles (see Figure 3AII) were very similar to those
obtained with the set of 8 muscles, and similar to those already
published by our group (Barroso et al., 2014). Synergy vectors
were also very similar between the 8- and 13-muscle datasets,
with the additional five muscles being incorporated within the
three synergy vectors (see Figure 3AI). Synergy 1 (involving
primarily hip flexor, knee extensor, and ankle dorsiflexor) mainly
provided force to start the upstroke phase of cycling in healthy
subjects. Synergy 2 (hip abductor, hip flexor, knee extensors and
ankle plantarflexor) contributed to the second part of upstroke
phase and also to the initial downstroke phase. Synergy 3
(hip extensors, knee flexors and ankle plantarflexors) activated
muscles responsible for downstroke phase of cycling.
In the healthy participants, antagonist muscles were not
activated by the same synergy (e.g., the quadriceps and
hamstrings, the TA and the Triceps Surae), in accordance with
the literature on walking (Clark et al., 2010) and cycling (Hug
et al., 2011). As expected, patients with no diagnosed spasticity
presented similar synergy vectors to the healthy people (levels of
co-activation of agonists/antagonists very low; see representative
patient from Figure 3CI). However, this was not the case of
some iSCI patients diagnosed with spasticity (see representative
patient from Figure 3BI). In this case, there was high variability
of muscle synergy vectors and activation coefficients across the
speeds, and also antagonist muscles were activated by the same
synergy (e.g., TA and Sol activated by synergy 3 in Figure 3BI).
Although spastic patients presented, on average, lower similarity
values (W ·W0 andH ·H0) than non-spastic patients, differences
were not statistically significant, except for the case of H2 · H02
at 30 rpm for the dataset of 13 muscles. This metric could also
predict Total MAS scores.
In general, muscle synergies composition of more impaired
patients was less similar to the healthy controls. We speculate
that patients with poor motor condition may have created
maladaptive plasticity that modified the existing muscle
synergies. When considering the whole iSCI group, similarity
with the healthy reference set was higher for the activation
coefficients than for the synergy vectors. We hypothesized that
these results may indicate less disruption of the corticospinal
drive (represented by activation coefficients) than the disruption
of the spinal organization (represented by the synergy vectors)
after SCI (Ivanenko et al., 2003; Ting et al., 2015).
Synergy 3 (activated during the downstroke phase of cycling)
from iSCI patients best correlated with the healthy group, for
both spastic and non-spastic patients. This has been observed in
the synergy vectors (W3 ·W03) and activation coefficients (H3 ·
H03), indicating less variability for this synergy composition
and activation. Therefore, we hypothesized that the similarity
scores for W1 and W2, as well as H1 and H2, which present
lower correlation values with the healthy group, would better
distinguish the spasticity levels of each patient.
Correlation with Clinical Metrics
Predictions of Gait Performance
Gait speed is an important outcome variable in clinical
assessment. The criteria used to include similar patients in
a group are usually based on classic clinical evaluations and
walking speed (Nadeau et al., 2011). Clark et al. (2010) reported
that the number of muscle synergies in post-stroke patients
correlated with the preferred walking speed. Also, Routson et al.
(2013) referred that those post-stroke patients that improved the
activation coefficients (more similar to the healthy group) also
improved walking performance. van Hedel et al. (2005) reported
that the 10-m test was more sensitive than the WISCI II in
demonstrating improvements in walking performance in iSCI
subjects. Based on these observations, and also on our previous
findings on similarity of muscle synergies between cycling and
walking (Barroso et al., 2014), we hypothesized that the analysis
of muscle synergies during cycling correlates with performance
scales related to gait speed, such as 10-m and TUG tests.
Our results showed positive significant correlations between
WISCI II and EMG reconstruction goodness scores (VAFtotal
and r2), when using the set of 13 muscles (see Table 5). In the
case of gait speed tests, r2 index correlated negatively with TUG
and 10-m tests, in both cases of 13 and 8 muscles. These results
are in accordance with the fact that patients with good walking
performance (lower time to perform TUG and 10-m test) and
lower amount of assistance needed (higher scores in the WISCI
II scale) present higher signal-to-noise ratio than those with
poor walking performance, as severely impaired subjects usually
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present reduced signal-to-noise ratio in the EMG signals due to
reduced signal strength (Lee et al., 2011). As a consequence of
lower signal-to-noise, lower VAFtotal and r
2 values are expected
(Steele et al., 2013).
In addition, 42 rpm seems to be the most appropriate speed to
assess motor performance in iSCI patients.
Predictions of Spasticity
The difficulty to classify a subject as spastic or not is a
well-known problem (Reichenfelser et al., 2012). Despite the
valuable information of pathophysiological mechanisms involved
in spasticity (Biering-Sørensen et al., 2006), there is still need for
novel tools capable of providing quantitativemetrics of spasticity,
with low intra and inter-rater variability (Gómez-Soriano et al.,
2012). In post-stroke patients, spasticity is characterized by high
levels of muscle tone and a relative absence of spasms, whereas in
iSCI patients, spasticity is mainly associated with the presence of
flexor and extensor spasms triggered by cutaneous stimulation
(Bennett, 2008). Ashworth and modified Ashworth scales are
commonly used to assess spasticity, although they specifically
measure hypertonia (Gómez-Soriano et al., 2012). It has been
previously suggested to combine them with a spasms frequency
scale to obtain more information of the spasticity of the iSCI
patient (Priebe et al., 1996).
Significant correlations were obtained when correlating
similarity of synergy vectors (W ·W0) with the spasms frequency
Penn scale, especially for the dataset of 8 muscles. W1 · W01
was the one with better correlation values with Penn scale. Also,
some correlations with clonus and extensor spasms assessed with
SCATS were also significant (p < 0.05) or presented p-values
between 0.05 and 0.1 for some of the synergy vectors and speeds.
Significant correlations were found between Total MAS scores
and H2 · H02 at low speeds. This indicates that H2 · H02 at low
speeds may be useful to assess the level of hypertonia, whereas
similarity of synergy vectors may be used to assess the spasms
frequency. On the other hand, these results also encourage a
wider use of Penn and SCATS scale to assess spasticity syndrome
in iSCI patients.
CONCLUSION
The primary goal of this study was to describe the synergistic
motor control of iSCI patients during cycling. Results showed
that SCI patients preserve a synergistic control of lower limb
muscles during cycling movements, evidence that was not
reported previously in the literature.
As a secondary goal, we positively tested the ability of muscle
synergy analysis during cycling movements to assess walking
functionality, as well as to quantify hypertonia and spasms, which
are important clinical conditions of spasticity present in iSCI
patients (Bennett, 2008).
Additionally, we explored the sensitivity of the method to
changes in speeds and number of muscles, being this information
relevant for efficient applicability in everyday clinical practice.
We found out that the analysis of 8 muscles was sufficient to
quantitatively assess spasticity of the lower limbs and also gait
performance, and that 42 rpm appears to be the most convenient
cycling speed for such analysis.
As future work, we are planning to test intra and inter-rater
variability of this tool, as well as to follow-up iSCI patients
during at least 9 months after the injury, in order to validate
this approach for long term monitoring and assessment of
different therapeutic interventions. Further application of this
tool by clinicians is also needed to facilitate consensus amongst
researchers on the use of the analysis of muscle activity (and
coordination) to extract quantitative metrics of neurologically
induced motor impairments.
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